The PANCREASThe newest edition of the essential guide to pancreatic medicine The fourth edition of The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery integrates the cutting-edge research of recent years to update its presentation of this fast-growing subject. It details every known disorder of the pancreas, grounding them in a thorough understanding of pancreatic function, enhanced with high quality illustration and graphs. It also includes step-by-step guidance for relevant endoscopic techniques and surgical procedures. The Pancreas readers will also find: New comprehensive insights into three pancreatic diseases: autoimmune pancreatitis, cystic neoplasms, and neuroendocrine tumors An editorial team with decades of clinical and research experience in the US, Europe, and Asia Over 500 downloadable illustrations for use in scientific presentations The Pancreas is a foundational reference for clinicians and researchers in gastroenterology and gastrointestinal surgery.

Provides findings on acute pancreatitis in the fields of morphology, epidemiology, pathophysiology, enzymatic and in- strumental diagnosis, clinical aspects and pharmacological and surgical treatment. Emphasis on clinical implications on the local release and vasoactice and toxic substances, the high rate of bacterial infection in the necroses, and the causes of impairment of cardiocirculatory, pulmonary and re- nal organs.

A variety of new cancer therapy modalities are discussed and evaluated in this book. It aims to demonstrate that the combination of classical chemo- and radiotherapy with new approaches in the field of immunotherapy can result in an improved treatment modality. Immunotherapy in this context consists of therapy with monoclonal antibodies, hematopoietic growth factors and other lymphokines. Results of early clinical trials with IL-2, GM-CSF and monoclonal antibodies against gastrointestinal tumors and melanoma are included. The progress in regional chemotherapy strategies, for example of the liver, is shown. In addition, the development of new chemotherapeutic agents with a different mode of action as well as better tolerability is presented. The use of hormones, such as LH-RH agonists, allows hormone-dependent tumors such as prostatic and breast cancer to be treated without strong adverse reactions. These recent findings give the reader insight into exciting therapeutic directions made possible by such combined, rather than single, modalities.

Im Chirurgischen Forum werden ausgew{hlte Beitr{ge vorab ver|ffentlicht, dieauf dem Kongre~ der Deutschen Gesellschaft f}r Chirurgie vorgetragen werden.Der Forumsausschu~ achtet dabei auf h|chste Qualit{t der Beitr{ge. Der Leser findet hier die neuesten Ergebnisse aus Forschung und Klinik }bersichtlich in einem Band.